Antiphospholipid syndrome, hyperhomocysteinaemia and normocalcemic hyperparathyroidism

• References

• 1 Nelen WL, Blom HJ, Steegers EA. et al. Hyperhomocysteinemia and recurrent early pregnancy loss: a meta-analysis. Fertil Steril 2000; 74: 1196-9.
• 2 den Heijer M, Rosendaal FR, Blom HJ. et al. Hyperhomocysteinemia and venous thrombosis: a meta-analysis. Thromb Haemost 1998; 80: 874-7.
• 3 Avivi I, Lanir N, Hoffman R. et al. Hyperhomocysteinemia is common in patients with antiphospholipid syndrome and may contribute to expression of major thrombotic events. Blood Coagul Fibrinolysis 2002; 13: 169-72.
• 4 Benekli M, Savas MC, Erdem Y. et al. Primary hyperparathyroidism in a patient with systemic lupus erythematosus-antiphospholipid syndrome. Nephron 1998; 79: 215-6.
• 5 Tordjman K, Greenman Y, Osher E. et al. Characterization of normocalcemic primary hyperparathyroidism. Am J Med 2004; 117: 861-3.
• 6 Kosch M, Hausberg M, Vormbrock K. et al. Studies on flow-mediated vasodilation and intima-media thickness of the brachial artery in patients with primary hyperparathyroidism. Am J Hypertens 2000; 13: 759-64.
• 7 Ames PR, Margarita A, Delgado Alves J. et al. Anticardiolipin antibody titre and plasma homocysteine level independently predict intima media thickness of carotid arteries in subjects with idiopathic antiphospholipid antibodies. Lupus 2002; 11: 208-14.
• 8 Mc Calum RW, Petrie JR, Dominicsak AF. et al. Growth hormone deficiency and vascular risk. Clin Endocrinol (Oxf) 2002; 57: 11-24.